PRTA
Prothena Corporation plc
NASDAQ: PRTA · HEALTHCARE · BIOTECHNOLOGY
$10.87
-5.56% today
Updated 2026-04-29
Market cap
$619.62M
P/E ratio
—
P/S ratio
63.98x
EPS (TTM)
$-4.53
Dividend yield
—
52W range
$4 – $12
Volume
0.5M
Prothena Corporation plc (PRTA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |